Game producer Youzu Interactive led a round that took the credit risk assessment platform’s overall funding to more than $50m.
Author: Robert Lavine
CNP helps Alan cover series A round
Returning investor CNP Assurances contributed to a $28.4m round led by Index Ventures that increased the health insurance startup’s total funding to $45m.
Symphony signs for $67m
Barclays, BPIfrance, CLSA and unnamed existing investors have increased the communication software provider’s overall funding to more than $300m.
Inspire Medical to make inroads on public markets
Medtronic spinout Inspire Medical Systems, the developer of a neurostimulation device for sleep apnea, has targeted $86.3m for its IPO.
Pivotal pinpoints $530m target for IPO
The Dell EMC spinout has set the range for an offering in which General Electric will sell up to $62m of shares.
Huya targets $200m as it joins IPO stream
The YY-founded live game streaming platform raised $462m from Tencent last month at a valuation of $1.16bn.
Foodspring reaps benefits of corporate backing
Fonterra Ventures and Ringier Digital Ventures both took part in a $27.1m round for the nutritional product brand.
Magenta Therapeutics manages $52m in series C
Access Industries contributed to a round that lifted the bone marrow transplant drug developer’s overall funding to $150m.
Unity Biotechnology gets to IPO age with $85m filing
The age-related disease drug developer, which counts Mayo Clinic and WuXi PharmaTech as investors, raised $55m as recently as last month.
Corporates help distribute funding to Origami Energy
Aggreko and Fred.Olsen both invested in distributed energy management platform developer Origami as part of a $26.3m round.
Octopus arms itself with $95m
The travel services marketplace secured the series C funding from Tempus Group, Ant Financial and CCB International.
Alibaba makes SenseTime’s $600m series C
The artificial intelligence technology producer secured the money at a reported $4.5bn valuation, with Alibaba leading the round and Suning also investing.
Abbott spots Bigfoot for $55m series B
Abbott has contributed to the $18m second tranche of diabetes management technology developer Bigfoot Biomedical’s latest round.
Branch International banks $70m
The emerging markets-focused online lender has raised debt and equity financing in a series B round featuring CreditEase Fintech Investment Fund.